Loading...

Context matters in MLL-AF9–driven leukemias

In this issue of Blood, Man et al demonstrate that the transforming activity of the leukemic fusion oncogene MLL-AF9 is regulated by inhibitor of DNA binding 1 (Id1), a dominant-negative regulator of E protein transcription factors.(1)

Saved in:
Bibliographic Details
Published in:Blood
Main Author: Park, Christopher Y.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4865586/
https://ncbi.nlm.nih.gov/pubmed/27206664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-704338
Tags: Add Tag
No Tags, Be the first to tag this record!